| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/12/2011 | CN101940553A Folic acid-vincristine targeted and slow-released nano-microspheres, prepared method and application thereof |
| 01/12/2011 | CN101940551A Self-assembly nano-particles of sulfhydrylation chitosan quaternary ammonium salt and preparation method and application thereof |
| 01/12/2011 | CN101940538A Xenon-containing cosmetics and preparation method thereof |
| 01/12/2011 | CN101642472B Oviductus ranae soft capsule manufacturing process |
| 01/12/2011 | CN101548955B Florfenicol lung targeting microspheres for animals and method for preparing same |
| 01/12/2011 | CN101513530B Polyhydroxyalkanoate (PHA) targeted carrier, drug-loading nano-particle and preparation methods and application thereof |
| 01/12/2011 | CN101480377B Method for preparing tumor enzyme-targeted nano medicine-carrying polymer microsphere |
| 01/12/2011 | CN101450041B Nano lycorine chloride microcapsule latex and preparation method thereof |
| 01/12/2011 | CN101433718B Biodegradable polypeptide vesicle loaded with hemoglobin and preparation method thereof |
| 01/12/2011 | CN101422433B Environment simulating sustained-release storage system and preparation method thereof |
| 01/12/2011 | CN101390826B Magnetic tumour target polymer nano vesicle and preparation method thereof |
| 01/12/2011 | CN101371877B Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same |
| 01/12/2011 | CN101330908B Adhesive preparation |
| 01/12/2011 | CN101327182B Preparation of nano crystal fibre felt of water-insoluble medicament |
| 01/12/2011 | CN101277699B Sustained-release preparation |
| 01/12/2011 | CN101269079B Emulsion composition comprising prostaglandin E1 |
| 01/12/2011 | CN101239187B Functionalization carbon nano-tube for tumor lympha targeted therapeutic carrier |
| 01/12/2011 | CN101214323B Orally-taken powder medicine and externally-applied plaster for treating angitis and preparation thereof |
| 01/12/2011 | CN101076354B Carrier used for medicine giving for intestine |
| 01/12/2011 | CN101032551B Hepatosis-treating Chinese traditional medicine |
| 01/11/2011 | US7868047 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues |
| 01/11/2011 | US7868044 FDA Orange book listed patent for adapalene (title compound); topical treatment using aqueous gels, creams, lotions or solutions with at least one polymeric emulsifier, modified cellulose, gum, starch, biopolymer or alginate; better therapeutic efficacy and good tolerance |
| 01/11/2011 | US7867990 Steroid hormone products and methods for preparing them |
| 01/11/2011 | US7867986 Enhanced drug delivery in transdermal systems |
| 01/11/2011 | US7867545 Homogenous granular solid matrix containing vegetable protein |
| 01/11/2011 | US7867527 synergistically reduces dark melanin production |
| 01/11/2011 | US7867518 Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof |
| 01/11/2011 | US7867517 Oral pharmaceutical composition with improved bioavailability |
| 01/11/2011 | US7867514 Mixing drugs such as cilostazol with sodium lauryl sulfate, neutral, basic compounds and optionally binders to form pills, tablets, particles, powders or capsules having storage stability; discoloration inhibition |
| 01/11/2011 | US7867513 applying capsule anti-sticking agent, enzymatically decomposed lecithin, on surface; improved water activity, disintegration property |
| 01/11/2011 | US7867509 Fast dissolving orally consumable films |
| 01/11/2011 | US7867499 VLP structure chemically coupled to a fragment of the A beta -1-42 peptide; Alzheimer's and Parkinson's disease |
| 01/11/2011 | US7867498 comprise at least five CD4+ T cell epitopes, for conjugation to capsular polysaccharides; for use in treatment and prevention of plasmodial infection; genetic vaccines; for immunization |
| 01/11/2011 | US7867481 Method of treating anemia by administering IL-1ra |
| 01/11/2011 | CA2690824C Methadone formulation |
| 01/11/2011 | CA2487590C Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 01/11/2011 | CA2461623C Water-in-oil emulsions with ethylene oxide groups, compostions, and methods |
| 01/11/2011 | CA2453996C Injectable pharmaceutical formulations |
| 01/11/2011 | CA2440172C Itraconazole solution |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/11/2011 | CA2374039C Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 01/11/2011 | CA2205092C Use of angiotensin ii fragments and analogs thereof in tissue repair |
| 01/09/2011 | CA2671595A1 Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes |
| 01/06/2011 | WO2011002852A2 Pro-drug complexes and related methods of use |
| 01/06/2011 | WO2011002077A1 Tnf-α gene therapy agent contained in polymeric micelle |
| 01/06/2011 | WO2011002034A1 Needle-like material |
| 01/06/2011 | WO2011001951A1 Ophthalmic composition |
| 01/06/2011 | WO2011001869A1 Method for producing nanospheres, nanospheres, external composition for skin containing same, and cosmetic preparation |
| 01/06/2011 | WO2011001780A1 Method for producing liposomes by two-stage emulsification method using outer aqueous phase containing specific dispersing agent, method for producing liposome dispersion or dry powder thereof using the method for producing liposomes, and liposome dispersion or dry powder thereof produced thereby |
| 01/06/2011 | WO2011001657A1 Polyionic dendrimer and hydrogel comprising same |
| 01/06/2011 | WO2011001634A1 Method for improving bioavailability of latanoprost |
| 01/06/2011 | WO2011001440A1 Pharmaceutical compositions of valsartan |
| 01/06/2011 | WO2011001276A1 Immunocytokines in combination with anti-erbb antibodies for the treatment of cancer |
| 01/06/2011 | WO2011000958A1 Compounds targeting the cation-independent mannose 6-phosphate receptor |
| 01/06/2011 | WO2011000889A1 Topical vaccine formulations and methods of treating drug addiction using same |
| 01/06/2011 | WO2011000210A1 Composition of permeation enhancer and use thereof in transdermal drug delivery system |
| 01/06/2011 | WO2011000208A1 Pharmaceutical composition containing dimethicone/ simethicone |
| 01/06/2011 | WO2011000126A1 Pharmaceutical composition of liposoluble drugs, preparation method and use thereof |
| 01/06/2011 | WO2011000108A1 Compositions and methods for silencing apolipoprotein b |
| 01/06/2011 | WO2011000106A1 Improved cationic lipids and methods for the delivery of therapeutic agents |
| 01/06/2011 | WO2011000095A1 Multimeric peptide conjugates and uses thereof |
| 01/06/2011 | WO2011000063A1 Aqueous solution of multicomponent inclusion compounds comprising gentamicin and iron il lactate in cy clodextrins, process for the manufacture thereof, use, method of the immunization and good health of domestic animals, kit, and pharmaceutical composition. |
| 01/06/2011 | WO2010132730A3 Hyaluronic acid (ha) injection vehicle |
| 01/06/2011 | WO2010119102A3 Pharmaceutical composition containing proton pump inhibitor for treating dermatological autoimmune diseases |
| 01/06/2011 | WO2010104819A3 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery |
| 01/06/2011 | WO2010102196A3 Controlled-release ophthalmic vehicles |
| 01/06/2011 | WO2010102192A3 Non-steroidal anti-inflammatory ophthalmic compositions |
| 01/06/2011 | WO2010099292A3 Biodegradable drug or other active delivery system |
| 01/06/2011 | WO2010098627A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010098625A3 Pharmaceutical preparation |
| 01/06/2011 | WO2010086880A4 A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
| 01/06/2011 | WO2010075010A3 Oligosaccharide-protein conjugates |
| 01/06/2011 | WO2010064207A3 Selective anticancer chimeric peptide |
| 01/06/2011 | WO2010028216A3 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 01/06/2011 | US20110004304 Culturing retinal cells and tissues |
| 01/06/2011 | US20110003898 Medical glues for surgery comprising bioactive compounds |
| 01/06/2011 | US20110003816 Ophthalmic composition |
| 01/06/2011 | US20110003770 Method and pharmaceutical to treat spinal discs |
| 01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
| 01/06/2011 | US20110002986 Stable Shellac Enteric Coating Formulation for Nutraceutical and Pharmaceutical Dosage Forms |
| 01/06/2011 | US20110002974 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002957 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002905 Compositions of fat-soluble active ingredients containing protein-polysaccharide conjugates |
| 01/06/2011 | US20110002875 Method for treating amyloidosis |
| 01/06/2011 | US20110002874 Polymer Network Compositions and Associated Methods |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | CA2767129A1 Compositions and methods for silencing apolipoprotein b |
| 01/06/2011 | CA2766614A1 Compounds targeting the cation-independent mannose 6-phosphate receptor |
| 01/06/2011 | CA2766537A1 Multimeric peptide conjugates and uses thereof |
| 01/06/2011 | CA2766388A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof |
| 01/06/2011 | CA2766269A1 Method for improving bioavailability of latanoprost |
| 01/06/2011 | CA2765836A1 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof |
| 01/05/2011 | EP2270107A1 Compounds for Dual Photodiagnosis and Therapy |
| 01/05/2011 | EP2270045A1 Antibodies against Clostridium difficile toxins and uses thereof |
| 01/05/2011 | EP2270037A2 Hasylated Factor IX |
| 01/05/2011 | EP2270036A2 Hasylated polypeptides |
| 01/05/2011 | EP2270035A2 Peptides enhancing CEH activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis |